Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
13.1M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
10.3M
-
Shares change
-
+395K
-
Total reported value, excl. options
-
$155M
-
Value change
-
+$6.78M
-
Number of buys
-
27
-
Number of sells
-
-9
-
Price
-
$15.00
Significant Holders of Forte Biosciences, Inc. - Common Stock, $0.001 par value (FBRX) as of Q3 2025
46 filings reported holding FBRX - Forte Biosciences, Inc. - Common Stock, $0.001 par value as of Q3 2025.
Forte Biosciences, Inc. - Common Stock, $0.001 par value (FBRX) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.3M shares
of 13.1M outstanding shares and own 79.14% of the company stock.
Largest 10 shareholders include FRED ALGER MANAGEMENT, LLC (1.64M shares), FEDERATED HERMES, INC. (1.64M shares), JANUS HENDERSON GROUP PLC (1.4M shares), ORBIMED ADVISORS LLC (1.2M shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (787K shares), VANGUARD GROUP INC (567K shares), Cable Car Capital, LP (500K shares), SPHERA FUNDS MANAGEMENT LTD. (474K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (333K shares), and Woodline Partners LP (332K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.